Serum miR-1290 as a Marker of Pancreatic Cancer-Letter

A.E. Frampton, J. Krell, G. Kazemier, E. Giovannetti

Research output: Contribution to journal › Article › Academic › peer-review

4 Citations (Scopus)

Access to Document

@article{e19c873a3a7448e6990e31238b784708,

title = "Serum miR-1290 as a Marker of Pancreatic Cancer-Letter",

author = "A.E. Frampton and J. Krell and G. Kazemier and E. Giovannetti",

year = "2013",

doi = "https://doi.org/10.1158/1078-0432.CCR-13-1620",

language = "Undefined/Unknown",

volume = "19",

pages = "5250--5251",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "18",

}

TY - JOUR

T1 - Serum miR-1290 as a Marker of Pancreatic Cancer-Letter

AU - Frampton, A.E.

AU - Krell, J.

AU - Kazemier, G.

AU - Giovannetti, E.

PY - 2013

Y1 - 2013

U2 - https://doi.org/10.1158/1078-0432.CCR-13-1620

DO - https://doi.org/10.1158/1078-0432.CCR-13-1620

M3 - Article

C2 - 23888071

SN - 1078-0432

VL - 19

SP - 5250

EP - 5251

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 18

ER -